The Arab Drug Company (EGX:ADCI)

The Arab Drug Company Revenue

The Arab Drug Company had revenue of 263.29M EGP in the quarter ending March 31, 2025, with 57.48% growth. This brings the company's revenue in the last twelve months to 1.03B, up 40.59% year-over-year. In the fiscal year ending June 30, 2024, The Arab Drug Company had annual revenue of 785.52M with 23.95% growth.

• Revenue (ttm): 1.03B
• Revenue Growth: +40.59%
• P/S Ratio: 2.69
• Revenue / Employee: 893.60K
• Employees: 1,152
• Market Cap: 2.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	785.52M	151.79M	23.95%
Jun 30, 2023	633.73M	128.69M	25.48%
Jun 30, 2022	505.04M	-32.01M	-5.96%
Jun 30, 2021	537.05M	16.25M	3.12%
Jun 30, 2020	520.80M	84.45M	19.35%